Wanda Liguigli

Mantova, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.

Journal: Clinical lung cancer

Published: January 11, 2026

Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy.

Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy.

Journal: BMC cancer

Published: May 30, 2018

First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study.

First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study.

Journal: Oncotarget

Published: July 20, 2017

Pharmacotherapy for treating metastatic clear cell renal cell carcinoma.

Pharmacotherapy for treating metastatic clear cell renal cell carcinoma.

Journal: Expert opinion on pharmacotherapy

Published: January 20, 2017

Safety and efficacy of dose-dense chemotherapy with TCF regimen in elderly patients with locally advanced or metastatic gastric cancer.

Safety and efficacy of dose-dense chemotherapy with TCF regimen in elderly patients with locally advanced or metastatic gastric cancer.

Journal: Tumori

Published: August 04, 2016

Targeted therapies in gastric cancer treatment: where we are and where we are going.

Targeted therapies in gastric cancer treatment: where we are and where we are going.

Journal: Investigational new drugs

Published: December 14, 2015

Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs).

Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs).

Journal: Journal of nephrology

Published: December 13, 2015

Tivantinib (ARQ197) in hepatocellular carcinoma.

Tivantinib (ARQ197) in hepatocellular carcinoma.

Journal: Expert review of anticancer therapy

Published: June 03, 2015

Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity.

Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity.

Journal: Future oncology (London, England)

Published: January 10, 2015

Ramucirumab for metastatic gastric or gastroesophageal junction cancer: results and implications of the REGARD trial.

Ramucirumab for metastatic gastric or gastroesophageal junction cancer: results and implications of the REGARD trial.

Journal: Future oncology (London, England)

Published: August 23, 2014

Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial.

Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: May 22, 2013

Narrative literature and cancer: improving the doctor-patient relationship.

Narrative literature and cancer: improving the doctor-patient relationship.

Journal: Tumori

Published: February 08, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026